SimonTeoh的个人主页 - 老虎社区

SimonTeoh

SimonTeoh

Play safe

IP属地：未知

24关注

2粉丝

0主题

0勋章

2021-07-10

Like

抱歉，原内容已删除

2021-08-19

$Atossa Genetics(ATOS)$Trust $ATOS

2021-12-16

$Atossa Genetics(ATOS)$Long wait

2021-07-27

$Plug Power(PLUG)$☝🏻

2021-07-22

$Plug Power(PLUG)$🚀🚀🚀

2021-07-14

$Atossa Genetics(ATOS)$Good deal😊

2021-07-10

Great

抱歉，原内容已删除

2021-11-05

$Surgalign Holdings, Inc.(SRGA)$Wake up

2021-07-12

$Atossa Genetics(ATOS)$🚀🚀🚀

2021-07-10

$$$

抱歉，原内容已删除

2021-07-31

$Atossa Genetics(ATOS)$I buy more to average ….. $Atos will be back soon

2021-07-13

Sounds good

抱歉，原内容已删除

2021-08-13

$Atossa Genetics(ATOS)$Come on

2021-07-26

Atos coming soon 🚀

2021-07-20

🚀🚀🚀

2021-07-12

Sounds good

Pfizer, U.S. health officials to discuss COVID boosters on Monday -company

2021-07-12

I’m buying

2021-07-10

Potential stocks

XPeng shares fell 3% in premarket trading.

2021-07-10

Ok

抱歉，原内容已删除

2021-07-10

Awaiting

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3570188731963577","uuid":"3570188731963577","gmtCreate":1607094708773,"gmtModify":1624711526339,"name":"SimonTeoh","pinyin":"simonteoh","introduction":"","introductionEn":"","signature":"Play safe","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":24,"tweetSize":22,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.25%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.04.21","exceedPercentage":"80.20%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.04.19","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.24","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":690637814,"gmtCreate":1639662686811,"gmtModify":1639662686889,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570188731963577","authorIdStr":"3570188731963577"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ATOS\">$Atossa Genetics(ATOS)$</a>Long wait&nbsp;","listText":"<a href=\"https://laohu8.com/S/ATOS\">$Atossa Genetics(ATOS)$</a>Long wait&nbsp;","text":"$Atossa Genetics(ATOS)$Long wait","images":[{"img":"https://static.tigerbbs.com/c103182f553853eea9010b87f690fc63","width":"1242","height":"2448"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690637814","isVote":1,"tweetType":1,"viewCount":1096,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":842004157,"gmtCreate":1636119266705,"gmtModify":1636119437810,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570188731963577","authorIdStr":"3570188731963577"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SRGA\">$Surgalign Holdings, Inc.(SRGA)$</a>Wake up","listText":"<a href=\"https://laohu8.com/S/SRGA\">$Surgalign Holdings, Inc.(SRGA)$</a>Wake up","text":"$Surgalign Holdings, Inc.(SRGA)$Wake up","images":[{"img":"https://static.tigerbbs.com/6c0ff2546acf92212be27d2ae4a90236","width":"1242","height":"2448"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/842004157","isVote":1,"tweetType":1,"viewCount":1331,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":838145113,"gmtCreate":1629382680832,"gmtModify":1631884384568,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570188731963577","authorIdStr":"3570188731963577"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ATOS\">$Atossa Genetics(ATOS)$</a>Trust $ATOS","listText":"<a href=\"https://laohu8.com/S/ATOS\">$Atossa Genetics(ATOS)$</a>Trust $ATOS","text":"$Atossa Genetics(ATOS)$Trust $ATOS","images":[{"img":"https://static.tigerbbs.com/b13bf482959bbea557576ddf3b6232d7","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/838145113","isVote":1,"tweetType":1,"viewCount":1499,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":897980926,"gmtCreate":1628868056265,"gmtModify":1631884384595,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570188731963577","authorIdStr":"3570188731963577"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ATOS\">$Atossa Genetics(ATOS)$</a>Come on","listText":"<a href=\"https://laohu8.com/S/ATOS\">$Atossa Genetics(ATOS)$</a>Come on","text":"$Atossa Genetics(ATOS)$Come on","images":[{"img":"https://static.tigerbbs.com/ac3ec033ff0de282a34271dcf2dc2e84","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/897980926","isVote":1,"tweetType":1,"viewCount":1091,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":806775939,"gmtCreate":1627696974821,"gmtModify":1631884384711,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570188731963577","authorIdStr":"3570188731963577"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ATOS\">$Atossa Genetics(ATOS)$</a>I buy more to average&nbsp;….. $Atos will be back soon&nbsp;","listText":"<a href=\"https://laohu8.com/S/ATOS\">$Atossa Genetics(ATOS)$</a>I buy more to average&nbsp;….. $Atos will be back soon&nbsp;","text":"$Atossa Genetics(ATOS)$I buy more to average ….. $Atos will be back soon","images":[{"img":"https://static.tigerbbs.com/fda1f1b3e87c2b8abfaa9fc76c1ddc72","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/806775939","isVote":1,"tweetType":1,"viewCount":1275,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":809328066,"gmtCreate":1627349046155,"gmtModify":1631888480800,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570188731963577","authorIdStr":"3570188731963577"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PLUG\">$Plug Power(PLUG)$</a>☝🏻","listText":"<a href=\"https://laohu8.com/S/PLUG\">$Plug Power(PLUG)$</a>☝🏻","text":"$Plug Power(PLUG)$☝🏻","images":[{"img":"https://static.tigerbbs.com/cf5c1491b5657a3cf3d27081803b817c","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/809328066","isVote":1,"tweetType":1,"viewCount":1995,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":800578798,"gmtCreate":1627310136814,"gmtModify":1631891492550,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570188731963577","authorIdStr":"3570188731963577"},"themes":[],"htmlText":"Atos coming soon 🚀","listText":"Atos coming soon 🚀","text":"Atos coming soon 🚀","images":[{"img":"https://static.tigerbbs.com/bae327c1d150ad15024e5ad444b06dc6","width":"1125","height":"2534"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/800578798","isVote":1,"tweetType":1,"viewCount":1867,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":172133630,"gmtCreate":1626942928420,"gmtModify":1631888480814,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570188731963577","authorIdStr":"3570188731963577"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PLUG\">$Plug Power(PLUG)$</a>🚀🚀🚀","listText":"<a href=\"https://laohu8.com/S/PLUG\">$Plug Power(PLUG)$</a>🚀🚀🚀","text":"$Plug Power(PLUG)$🚀🚀🚀","images":[{"img":"https://static.tigerbbs.com/b677286e01542f28218968458be8fde6","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/172133630","isVote":1,"tweetType":1,"viewCount":1416,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":171727850,"gmtCreate":1626767217370,"gmtModify":1631891492553,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570188731963577","authorIdStr":"3570188731963577"},"themes":[],"htmlText":"🚀🚀🚀","listText":"🚀🚀🚀","text":"🚀🚀🚀","images":[{"img":"https://static.tigerbbs.com/1f038b38ab74c240bcb3fbea0736bd9f","width":"1125","height":"3313"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/171727850","isVote":1,"tweetType":1,"viewCount":2147,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":144996184,"gmtCreate":1626258951648,"gmtModify":1631884384925,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570188731963577","authorIdStr":"3570188731963577"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ATOS\">$Atossa Genetics(ATOS)$</a>Good deal😊","listText":"<a href=\"https://laohu8.com/S/ATOS\">$Atossa Genetics(ATOS)$</a>Good deal😊","text":"$Atossa Genetics(ATOS)$Good deal😊","images":[{"img":"https://static.tigerbbs.com/222b0e224045530d20d8e06690c0c744","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/144996184","isVote":1,"tweetType":1,"viewCount":718,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":142451073,"gmtCreate":1626170637292,"gmtModify":1631891492554,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570188731963577","authorIdStr":"3570188731963577"},"themes":[],"htmlText":"Sounds good&nbsp;","listText":"Sounds good&nbsp;","text":"Sounds good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/142451073","repostId":"2151964557","repostType":2,"isVote":1,"tweetType":1,"viewCount":220,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":148755609,"gmtCreate":1626023264101,"gmtModify":1631891492558,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570188731963577","authorIdStr":"3570188731963577"},"themes":[],"htmlText":"Sounds good&nbsp;","listText":"Sounds good&nbsp;","text":"Sounds good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/148755609","repostId":"2150330031","repostType":2,"repost":{"id":"2150330031","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1626022227,"share":"https://www.laohu8.com/m/news/2150330031?lang=&edition=full","pubTime":"2021-07-12 00:50","market":"us","language":"en","title":"Pfizer, U.S. health officials to discuss COVID boosters on Monday -company","url":"https://stock-news.laohu8.com/highlight/detail?id=2150330031","media":"Reuters","summary":"WASHINGTON, July 11 (Reuters) - COVID-19 vaccine maker Pfizer Inc    will meet with federal health o","content":"<html><body><p>WASHINGTON, July 11 (Reuters) - COVID-19 vaccine maker Pfizer Inc    will meet with federal health officials as soon as Monday to discuss the need for a booster dose of the coronavirus vaccine as it prepares to seek authorization, the company said on Sunday. </p><p>   The meeting comes days after the drugmaker and its partner  <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a>    announced plans to seek U.S. and European regulatory approval for a third dose of their COVID-19 shot amid the spread of variants and data they said showed heightened risk of infection six months after initial inoculation. </p><p>   That push prompted a quick response from the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention, saying Americans do not need a booster right now.</p><p>   On Monday, Pfizer is scheduled to meet with representatives of the FDA, a company spokesperson said. The meeting was first reported by the Washington Post.</p><p>   Representatives for the U.S. Department of Health and Human Services did not immediately respond to a request for comment. </p><p>   Anthony Fauci, President Joe Biden’s chief medical adviser who also directs the National Institute of Allergy and Infectious Diseases, as well as the heads of the National Institutes of Health and the CDC were also among those invited to the briefing, which could move to another day, according to the Post's report.     </p><p>   Fauci, in several television interviews on Sunday, said U.S. health officials were not dismissing the possible future need for boosters -- especially as breakthrough infections among those who have been vaccinated have emerged -- but that more data is needed for any formal recommendation.     </p><p>   \"There's a lot of dynamic things going on right now,\" he told ABC News' \"This Week\" program. </p><p>   \"There are studies being done now ongoing as we speak about looking at the feasibility about if and when we should be boosting people... there's a lot of work going on to examine this in real time,\" he added on CNN's \"State of the Union.\" </p><p>   Despite the FDA and CDC's statement, \"that doesn't mean that we're not very, very actively following and gathering all of this information to see if and when we might need it and if and when we do, we'll have everything in place to do it.\"    </p><p>   U.S. health officials are still struggling to get people in some areas to receive their initial inoculations as the highly contagious Delta variant has grown to be the nation's dominant strain, with COVID-19 cases rising mostly among the unvaccinated.  </p><p>   European officials has also said vaccines currently seem protective against variants. Canada has also said it is monitoring variants and the possible need for boosters.</p><p>   While some scientists have also questioned the need for booster shots, others have said they could be beneficial for the elderly and other vulnerable populations, although it is unclear when they would be needed.  </p><p>   Some public health experts have also expressed concern that authorizing boosters in wealthy developed nations while other countries are still struggling against initial inoculations will further exacerbate vaccine inequity.</p><p> (Reporting by Susan Heavey and Chris Prentice; additional reporting by Linda So; Editing by Chizu Nomiyama)</p><p>((sheavey@thomsonreuters.com; +1-202-898-8300;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer, U.S. health officials to discuss COVID boosters on Monday -company</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer, U.S. health officials to discuss COVID boosters on Monday -company\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-12 00:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>WASHINGTON, July 11 (Reuters) - COVID-19 vaccine maker Pfizer Inc    will meet with federal health officials as soon as Monday to discuss the need for a booster dose of the coronavirus vaccine as it prepares to seek authorization, the company said on Sunday. </p><p>   The meeting comes days after the drugmaker and its partner  <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a>    announced plans to seek U.S. and European regulatory approval for a third dose of their COVID-19 shot amid the spread of variants and data they said showed heightened risk of infection six months after initial inoculation. </p><p>   That push prompted a quick response from the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention, saying Americans do not need a booster right now.</p><p>   On Monday, Pfizer is scheduled to meet with representatives of the FDA, a company spokesperson said. The meeting was first reported by the Washington Post.</p><p>   Representatives for the U.S. Department of Health and Human Services did not immediately respond to a request for comment. </p><p>   Anthony Fauci, President Joe Biden’s chief medical adviser who also directs the National Institute of Allergy and Infectious Diseases, as well as the heads of the National Institutes of Health and the CDC were also among those invited to the briefing, which could move to another day, according to the Post's report.     </p><p>   Fauci, in several television interviews on Sunday, said U.S. health officials were not dismissing the possible future need for boosters -- especially as breakthrough infections among those who have been vaccinated have emerged -- but that more data is needed for any formal recommendation.     </p><p>   \"There's a lot of dynamic things going on right now,\" he told ABC News' \"This Week\" program. </p><p>   \"There are studies being done now ongoing as we speak about looking at the feasibility about if and when we should be boosting people... there's a lot of work going on to examine this in real time,\" he added on CNN's \"State of the Union.\" </p><p>   Despite the FDA and CDC's statement, \"that doesn't mean that we're not very, very actively following and gathering all of this information to see if and when we might need it and if and when we do, we'll have everything in place to do it.\"    </p><p>   U.S. health officials are still struggling to get people in some areas to receive their initial inoculations as the highly contagious Delta variant has grown to be the nation's dominant strain, with COVID-19 cases rising mostly among the unvaccinated.  </p><p>   European officials has also said vaccines currently seem protective against variants. Canada has also said it is monitoring variants and the possible need for boosters.</p><p>   While some scientists have also questioned the need for booster shots, others have said they could be beneficial for the elderly and other vulnerable populations, although it is unclear when they would be needed.  </p><p>   Some public health experts have also expressed concern that authorizing boosters in wealthy developed nations while other countries are still struggling against initial inoculations will further exacerbate vaccine inequity.</p><p> (Reporting by Susan Heavey and Chris Prentice; additional reporting by Linda So; Editing by Chizu Nomiyama)</p><p>((sheavey@thomsonreuters.com; +1-202-898-8300;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2150330031","content_text":"WASHINGTON, July 11 (Reuters) - COVID-19 vaccine maker Pfizer Inc    will meet with federal health officials as soon as Monday to discuss the need for a booster dose of the coronavirus vaccine as it prepares to seek authorization, the company said on Sunday.    The meeting comes days after the drugmaker and its partner  BioNTech SE    announced plans to seek U.S. and European regulatory approval for a third dose of their COVID-19 shot amid the spread of variants and data they said showed heightened risk of infection six months after initial inoculation.    That push prompted a quick response from the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention, saying Americans do not need a booster right now.   On Monday, Pfizer is scheduled to meet with representatives of the FDA, a company spokesperson said. The meeting was first reported by the Washington Post.   Representatives for the U.S. Department of Health and Human Services did not immediately respond to a request for comment.    Anthony Fauci, President Joe Biden’s chief medical adviser who also directs the National Institute of Allergy and Infectious Diseases, as well as the heads of the National Institutes of Health and the CDC were also among those invited to the briefing, which could move to another day, according to the Post's report.        Fauci, in several television interviews on Sunday, said U.S. health officials were not dismissing the possible future need for boosters -- especially as breakthrough infections among those who have been vaccinated have emerged -- but that more data is needed for any formal recommendation.        \"There's a lot of dynamic things going on right now,\" he told ABC News' \"This Week\" program.    \"There are studies being done now ongoing as we speak about looking at the feasibility about if and when we should be boosting people... there's a lot of work going on to examine this in real time,\" he added on CNN's \"State of the Union.\"    Despite the FDA and CDC's statement, \"that doesn't mean that we're not very, very actively following and gathering all of this information to see if and when we might need it and if and when we do, we'll have everything in place to do it.\"       U.S. health officials are still struggling to get people in some areas to receive their initial inoculations as the highly contagious Delta variant has grown to be the nation's dominant strain, with COVID-19 cases rising mostly among the unvaccinated.     European officials has also said vaccines currently seem protective against variants. Canada has also said it is monitoring variants and the possible need for boosters.   While some scientists have also questioned the need for booster shots, others have said they could be beneficial for the elderly and other vulnerable populations, although it is unclear when they would be needed.     Some public health experts have also expressed concern that authorizing boosters in wealthy developed nations while other countries are still struggling against initial inoculations will further exacerbate vaccine inequity. (Reporting by Susan Heavey and Chris Prentice; additional reporting by Linda So; Editing by Chizu Nomiyama)((sheavey@thomsonreuters.com; +1-202-898-8300;))","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":252,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":148752766,"gmtCreate":1626022943655,"gmtModify":1631884384963,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570188731963577","authorIdStr":"3570188731963577"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ATOS\">$Atossa Genetics(ATOS)$</a>🚀🚀🚀","listText":"<a href=\"https://laohu8.com/S/ATOS\">$Atossa Genetics(ATOS)$</a>🚀🚀🚀","text":"$Atossa Genetics(ATOS)$🚀🚀🚀","images":[{"img":"https://static.tigerbbs.com/05dc47b34c0ada1e3fefade7399550f5","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/148752766","isVote":1,"tweetType":1,"viewCount":283,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":148752921,"gmtCreate":1626022749663,"gmtModify":1631891492561,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570188731963577","authorIdStr":"3570188731963577"},"themes":[],"htmlText":"I’m buying&nbsp;","listText":"I’m buying&nbsp;","text":"I’m buying","images":[{"img":"https://static.tigerbbs.com/2a3918a00d848814cb589d5e7d2c62ad","width":"1125","height":"3068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/148752921","isVote":1,"tweetType":1,"viewCount":321,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":148975394,"gmtCreate":1625924179218,"gmtModify":1631891492566,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570188731963577","authorIdStr":"3570188731963577"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/148975394","repostId":"2150370120","repostType":4,"isVote":1,"tweetType":1,"viewCount":662,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":148972644,"gmtCreate":1625924061388,"gmtModify":1631891492568,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570188731963577","authorIdStr":"3570188731963577"},"themes":[],"htmlText":"$$$","listText":"$$$","text":"$$$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/148972644","repostId":"1140589344","repostType":2,"isVote":1,"tweetType":1,"viewCount":290,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":148976319,"gmtCreate":1625923866031,"gmtModify":1631891492570,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570188731963577","authorIdStr":"3570188731963577"},"themes":[],"htmlText":"Potential stocks","listText":"Potential stocks","text":"Potential stocks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/148976319","repostId":"1131738801","repostType":2,"repost":{"id":"1131738801","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1625645247,"share":"https://www.laohu8.com/m/news/1131738801?lang=&edition=full","pubTime":"2021-07-07 16:07","market":"us","language":"en","title":"XPeng shares fell 3% in premarket trading.","url":"https://stock-news.laohu8.com/highlight/detail?id=1131738801","media":"Tiger Newspress","summary":"XPeng shares fell 3% in premarket trading.\nShares of Chinese electric vehicle maker Xpeng Inc trade ","content":"<p>XPeng&nbsp;shares&nbsp;fell 3% in premarket&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/bfcb0a6ca8a7d5337dcf5cc5e4831321\" tg-width=\"1284\" tg-height=\"619\">Shares of Chinese electric vehicle&nbsp;maker Xpeng Inc&nbsp;trade as low as HK$159.30, down 3.5% from the offer price of HK$165 apiece in the company's dual primary listing debut in Hong Kong.</p>\n<p>Xpeng, which on Wednesday raised $1.8 bln by selling 85 mln shares in Hong Kong listing, will develop future models based on product platforms designed for international markets, its chief executive said</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>XPeng shares fell 3% in premarket trading.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nXPeng shares fell 3% in premarket trading.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-07-07 16:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>XPeng&nbsp;shares&nbsp;fell 3% in premarket&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/bfcb0a6ca8a7d5337dcf5cc5e4831321\" tg-width=\"1284\" tg-height=\"619\">Shares of Chinese electric vehicle&nbsp;maker Xpeng Inc&nbsp;trade as low as HK$159.30, down 3.5% from the offer price of HK$165 apiece in the company's dual primary listing debut in Hong Kong.</p>\n<p>Xpeng, which on Wednesday raised $1.8 bln by selling 85 mln shares in Hong Kong listing, will develop future models based on product platforms designed for international markets, its chief executive said</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"XPEV":"小鹏汽车"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1131738801","content_text":"XPeng shares fell 3% in premarket trading.\nShares of Chinese electric vehicle maker Xpeng Inc trade as low as HK$159.30, down 3.5% from the offer price of HK$165 apiece in the company's dual primary listing debut in Hong Kong.\nXpeng, which on Wednesday raised $1.8 bln by selling 85 mln shares in Hong Kong listing, will develop future models based on product platforms designed for international markets, its chief executive said","news_type":1,"symbols_score_info":{"XPEV":0.9}},"isVote":1,"tweetType":1,"viewCount":278,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":148978296,"gmtCreate":1625923806115,"gmtModify":1631891492572,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570188731963577","authorIdStr":"3570188731963577"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/148978296","repostId":"2149399869","repostType":2,"isVote":1,"tweetType":1,"viewCount":291,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":148971382,"gmtCreate":1625923653046,"gmtModify":1631891492576,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570188731963577","authorIdStr":"3570188731963577"},"themes":[],"htmlText":"Awaiting&nbsp;","listText":"Awaiting&nbsp;","text":"Awaiting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/148971382","repostId":"1181198369","repostType":2,"isVote":1,"tweetType":1,"viewCount":486,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":148948323,"gmtCreate":1625922572762,"gmtModify":1633936104159,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570188731963577","authorIdStr":"3570188731963577"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/148948323","repostId":"2150370120","repostType":4,"isVote":1,"tweetType":1,"viewCount":458,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":148975394,"gmtCreate":1625924179218,"gmtModify":1631891492566,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3570188731963577","idStr":"3570188731963577"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/148975394","repostId":"2150370120","repostType":4,"isVote":1,"tweetType":1,"viewCount":662,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":838145113,"gmtCreate":1629382680832,"gmtModify":1631884384568,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3570188731963577","idStr":"3570188731963577"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ATOS\">$Atossa Genetics(ATOS)$</a>Trust $ATOS","listText":"<a href=\"https://laohu8.com/S/ATOS\">$Atossa Genetics(ATOS)$</a>Trust $ATOS","text":"$Atossa Genetics(ATOS)$Trust $ATOS","images":[{"img":"https://static.tigerbbs.com/b13bf482959bbea557576ddf3b6232d7","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/838145113","isVote":1,"tweetType":1,"viewCount":1499,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":690637814,"gmtCreate":1639662686811,"gmtModify":1639662686889,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3570188731963577","idStr":"3570188731963577"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ATOS\">$Atossa Genetics(ATOS)$</a>Long wait&nbsp;","listText":"<a href=\"https://laohu8.com/S/ATOS\">$Atossa Genetics(ATOS)$</a>Long wait&nbsp;","text":"$Atossa Genetics(ATOS)$Long wait","images":[{"img":"https://static.tigerbbs.com/c103182f553853eea9010b87f690fc63","width":"1242","height":"2448"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690637814","isVote":1,"tweetType":1,"viewCount":1096,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":809328066,"gmtCreate":1627349046155,"gmtModify":1631888480800,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3570188731963577","idStr":"3570188731963577"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PLUG\">$Plug Power(PLUG)$</a>☝🏻","listText":"<a href=\"https://laohu8.com/S/PLUG\">$Plug Power(PLUG)$</a>☝🏻","text":"$Plug Power(PLUG)$☝🏻","images":[{"img":"https://static.tigerbbs.com/cf5c1491b5657a3cf3d27081803b817c","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/809328066","isVote":1,"tweetType":1,"viewCount":1995,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":172133630,"gmtCreate":1626942928420,"gmtModify":1631888480814,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3570188731963577","idStr":"3570188731963577"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PLUG\">$Plug Power(PLUG)$</a>🚀🚀🚀","listText":"<a href=\"https://laohu8.com/S/PLUG\">$Plug Power(PLUG)$</a>🚀🚀🚀","text":"$Plug Power(PLUG)$🚀🚀🚀","images":[{"img":"https://static.tigerbbs.com/b677286e01542f28218968458be8fde6","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/172133630","isVote":1,"tweetType":1,"viewCount":1416,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":144996184,"gmtCreate":1626258951648,"gmtModify":1631884384925,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3570188731963577","idStr":"3570188731963577"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ATOS\">$Atossa Genetics(ATOS)$</a>Good deal😊","listText":"<a href=\"https://laohu8.com/S/ATOS\">$Atossa Genetics(ATOS)$</a>Good deal😊","text":"$Atossa Genetics(ATOS)$Good deal😊","images":[{"img":"https://static.tigerbbs.com/222b0e224045530d20d8e06690c0c744","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/144996184","isVote":1,"tweetType":1,"viewCount":718,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":148948323,"gmtCreate":1625922572762,"gmtModify":1633936104159,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3570188731963577","idStr":"3570188731963577"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/148948323","repostId":"2150370120","repostType":4,"isVote":1,"tweetType":1,"viewCount":458,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":842004157,"gmtCreate":1636119266705,"gmtModify":1636119437810,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3570188731963577","idStr":"3570188731963577"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SRGA\">$Surgalign Holdings, Inc.(SRGA)$</a>Wake up","listText":"<a href=\"https://laohu8.com/S/SRGA\">$Surgalign Holdings, Inc.(SRGA)$</a>Wake up","text":"$Surgalign Holdings, Inc.(SRGA)$Wake up","images":[{"img":"https://static.tigerbbs.com/6c0ff2546acf92212be27d2ae4a90236","width":"1242","height":"2448"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/842004157","isVote":1,"tweetType":1,"viewCount":1331,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":148752766,"gmtCreate":1626022943655,"gmtModify":1631884384963,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3570188731963577","idStr":"3570188731963577"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ATOS\">$Atossa Genetics(ATOS)$</a>🚀🚀🚀","listText":"<a href=\"https://laohu8.com/S/ATOS\">$Atossa Genetics(ATOS)$</a>🚀🚀🚀","text":"$Atossa Genetics(ATOS)$🚀🚀🚀","images":[{"img":"https://static.tigerbbs.com/05dc47b34c0ada1e3fefade7399550f5","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/148752766","isVote":1,"tweetType":1,"viewCount":283,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":148972644,"gmtCreate":1625924061388,"gmtModify":1631891492568,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3570188731963577","idStr":"3570188731963577"},"themes":[],"htmlText":"$$$","listText":"$$$","text":"$$$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/148972644","repostId":"1140589344","repostType":2,"isVote":1,"tweetType":1,"viewCount":290,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":806775939,"gmtCreate":1627696974821,"gmtModify":1631884384711,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3570188731963577","idStr":"3570188731963577"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ATOS\">$Atossa Genetics(ATOS)$</a>I buy more to average&nbsp;….. $Atos will be back soon&nbsp;","listText":"<a href=\"https://laohu8.com/S/ATOS\">$Atossa Genetics(ATOS)$</a>I buy more to average&nbsp;….. $Atos will be back soon&nbsp;","text":"$Atossa Genetics(ATOS)$I buy more to average ….. $Atos will be back soon","images":[{"img":"https://static.tigerbbs.com/fda1f1b3e87c2b8abfaa9fc76c1ddc72","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/806775939","isVote":1,"tweetType":1,"viewCount":1275,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":142451073,"gmtCreate":1626170637292,"gmtModify":1631891492554,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3570188731963577","idStr":"3570188731963577"},"themes":[],"htmlText":"Sounds good&nbsp;","listText":"Sounds good&nbsp;","text":"Sounds good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/142451073","repostId":"2151964557","repostType":2,"isVote":1,"tweetType":1,"viewCount":220,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":897980926,"gmtCreate":1628868056265,"gmtModify":1631884384595,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3570188731963577","idStr":"3570188731963577"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ATOS\">$Atossa Genetics(ATOS)$</a>Come on","listText":"<a href=\"https://laohu8.com/S/ATOS\">$Atossa Genetics(ATOS)$</a>Come on","text":"$Atossa Genetics(ATOS)$Come on","images":[{"img":"https://static.tigerbbs.com/ac3ec033ff0de282a34271dcf2dc2e84","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/897980926","isVote":1,"tweetType":1,"viewCount":1091,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":800578798,"gmtCreate":1627310136814,"gmtModify":1631891492550,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3570188731963577","idStr":"3570188731963577"},"themes":[],"htmlText":"Atos coming soon 🚀","listText":"Atos coming soon 🚀","text":"Atos coming soon 🚀","images":[{"img":"https://static.tigerbbs.com/bae327c1d150ad15024e5ad444b06dc6","width":"1125","height":"2534"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/800578798","isVote":1,"tweetType":1,"viewCount":1867,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":171727850,"gmtCreate":1626767217370,"gmtModify":1631891492553,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3570188731963577","idStr":"3570188731963577"},"themes":[],"htmlText":"🚀🚀🚀","listText":"🚀🚀🚀","text":"🚀🚀🚀","images":[{"img":"https://static.tigerbbs.com/1f038b38ab74c240bcb3fbea0736bd9f","width":"1125","height":"3313"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/171727850","isVote":1,"tweetType":1,"viewCount":2147,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":148755609,"gmtCreate":1626023264101,"gmtModify":1631891492558,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3570188731963577","idStr":"3570188731963577"},"themes":[],"htmlText":"Sounds good&nbsp;","listText":"Sounds good&nbsp;","text":"Sounds good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/148755609","repostId":"2150330031","repostType":2,"repost":{"id":"2150330031","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1626022227,"share":"https://www.laohu8.com/m/news/2150330031?lang=&edition=full","pubTime":"2021-07-12 00:50","market":"us","language":"en","title":"Pfizer, U.S. health officials to discuss COVID boosters on Monday -company","url":"https://stock-news.laohu8.com/highlight/detail?id=2150330031","media":"Reuters","summary":"WASHINGTON, July 11 (Reuters) - COVID-19 vaccine maker Pfizer Inc    will meet with federal health o","content":"<html><body><p>WASHINGTON, July 11 (Reuters) - COVID-19 vaccine maker Pfizer Inc    will meet with federal health officials as soon as Monday to discuss the need for a booster dose of the coronavirus vaccine as it prepares to seek authorization, the company said on Sunday. </p><p>   The meeting comes days after the drugmaker and its partner  <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a>    announced plans to seek U.S. and European regulatory approval for a third dose of their COVID-19 shot amid the spread of variants and data they said showed heightened risk of infection six months after initial inoculation. </p><p>   That push prompted a quick response from the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention, saying Americans do not need a booster right now.</p><p>   On Monday, Pfizer is scheduled to meet with representatives of the FDA, a company spokesperson said. The meeting was first reported by the Washington Post.</p><p>   Representatives for the U.S. Department of Health and Human Services did not immediately respond to a request for comment. </p><p>   Anthony Fauci, President Joe Biden’s chief medical adviser who also directs the National Institute of Allergy and Infectious Diseases, as well as the heads of the National Institutes of Health and the CDC were also among those invited to the briefing, which could move to another day, according to the Post's report.     </p><p>   Fauci, in several television interviews on Sunday, said U.S. health officials were not dismissing the possible future need for boosters -- especially as breakthrough infections among those who have been vaccinated have emerged -- but that more data is needed for any formal recommendation.     </p><p>   \"There's a lot of dynamic things going on right now,\" he told ABC News' \"This Week\" program. </p><p>   \"There are studies being done now ongoing as we speak about looking at the feasibility about if and when we should be boosting people... there's a lot of work going on to examine this in real time,\" he added on CNN's \"State of the Union.\" </p><p>   Despite the FDA and CDC's statement, \"that doesn't mean that we're not very, very actively following and gathering all of this information to see if and when we might need it and if and when we do, we'll have everything in place to do it.\"    </p><p>   U.S. health officials are still struggling to get people in some areas to receive their initial inoculations as the highly contagious Delta variant has grown to be the nation's dominant strain, with COVID-19 cases rising mostly among the unvaccinated.  </p><p>   European officials has also said vaccines currently seem protective against variants. Canada has also said it is monitoring variants and the possible need for boosters.</p><p>   While some scientists have also questioned the need for booster shots, others have said they could be beneficial for the elderly and other vulnerable populations, although it is unclear when they would be needed.  </p><p>   Some public health experts have also expressed concern that authorizing boosters in wealthy developed nations while other countries are still struggling against initial inoculations will further exacerbate vaccine inequity.</p><p> (Reporting by Susan Heavey and Chris Prentice; additional reporting by Linda So; Editing by Chizu Nomiyama)</p><p>((sheavey@thomsonreuters.com; +1-202-898-8300;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer, U.S. health officials to discuss COVID boosters on Monday -company</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer, U.S. health officials to discuss COVID boosters on Monday -company\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-12 00:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>WASHINGTON, July 11 (Reuters) - COVID-19 vaccine maker Pfizer Inc    will meet with federal health officials as soon as Monday to discuss the need for a booster dose of the coronavirus vaccine as it prepares to seek authorization, the company said on Sunday. </p><p>   The meeting comes days after the drugmaker and its partner  <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a>    announced plans to seek U.S. and European regulatory approval for a third dose of their COVID-19 shot amid the spread of variants and data they said showed heightened risk of infection six months after initial inoculation. </p><p>   That push prompted a quick response from the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention, saying Americans do not need a booster right now.</p><p>   On Monday, Pfizer is scheduled to meet with representatives of the FDA, a company spokesperson said. The meeting was first reported by the Washington Post.</p><p>   Representatives for the U.S. Department of Health and Human Services did not immediately respond to a request for comment. </p><p>   Anthony Fauci, President Joe Biden’s chief medical adviser who also directs the National Institute of Allergy and Infectious Diseases, as well as the heads of the National Institutes of Health and the CDC were also among those invited to the briefing, which could move to another day, according to the Post's report.     </p><p>   Fauci, in several television interviews on Sunday, said U.S. health officials were not dismissing the possible future need for boosters -- especially as breakthrough infections among those who have been vaccinated have emerged -- but that more data is needed for any formal recommendation.     </p><p>   \"There's a lot of dynamic things going on right now,\" he told ABC News' \"This Week\" program. </p><p>   \"There are studies being done now ongoing as we speak about looking at the feasibility about if and when we should be boosting people... there's a lot of work going on to examine this in real time,\" he added on CNN's \"State of the Union.\" </p><p>   Despite the FDA and CDC's statement, \"that doesn't mean that we're not very, very actively following and gathering all of this information to see if and when we might need it and if and when we do, we'll have everything in place to do it.\"    </p><p>   U.S. health officials are still struggling to get people in some areas to receive their initial inoculations as the highly contagious Delta variant has grown to be the nation's dominant strain, with COVID-19 cases rising mostly among the unvaccinated.  </p><p>   European officials has also said vaccines currently seem protective against variants. Canada has also said it is monitoring variants and the possible need for boosters.</p><p>   While some scientists have also questioned the need for booster shots, others have said they could be beneficial for the elderly and other vulnerable populations, although it is unclear when they would be needed.  </p><p>   Some public health experts have also expressed concern that authorizing boosters in wealthy developed nations while other countries are still struggling against initial inoculations will further exacerbate vaccine inequity.</p><p> (Reporting by Susan Heavey and Chris Prentice; additional reporting by Linda So; Editing by Chizu Nomiyama)</p><p>((sheavey@thomsonreuters.com; +1-202-898-8300;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2150330031","content_text":"WASHINGTON, July 11 (Reuters) - COVID-19 vaccine maker Pfizer Inc    will meet with federal health officials as soon as Monday to discuss the need for a booster dose of the coronavirus vaccine as it prepares to seek authorization, the company said on Sunday.    The meeting comes days after the drugmaker and its partner  BioNTech SE    announced plans to seek U.S. and European regulatory approval for a third dose of their COVID-19 shot amid the spread of variants and data they said showed heightened risk of infection six months after initial inoculation.    That push prompted a quick response from the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention, saying Americans do not need a booster right now.   On Monday, Pfizer is scheduled to meet with representatives of the FDA, a company spokesperson said. The meeting was first reported by the Washington Post.   Representatives for the U.S. Department of Health and Human Services did not immediately respond to a request for comment.    Anthony Fauci, President Joe Biden’s chief medical adviser who also directs the National Institute of Allergy and Infectious Diseases, as well as the heads of the National Institutes of Health and the CDC were also among those invited to the briefing, which could move to another day, according to the Post's report.        Fauci, in several television interviews on Sunday, said U.S. health officials were not dismissing the possible future need for boosters -- especially as breakthrough infections among those who have been vaccinated have emerged -- but that more data is needed for any formal recommendation.        \"There's a lot of dynamic things going on right now,\" he told ABC News' \"This Week\" program.    \"There are studies being done now ongoing as we speak about looking at the feasibility about if and when we should be boosting people... there's a lot of work going on to examine this in real time,\" he added on CNN's \"State of the Union.\"    Despite the FDA and CDC's statement, \"that doesn't mean that we're not very, very actively following and gathering all of this information to see if and when we might need it and if and when we do, we'll have everything in place to do it.\"       U.S. health officials are still struggling to get people in some areas to receive their initial inoculations as the highly contagious Delta variant has grown to be the nation's dominant strain, with COVID-19 cases rising mostly among the unvaccinated.     European officials has also said vaccines currently seem protective against variants. Canada has also said it is monitoring variants and the possible need for boosters.   While some scientists have also questioned the need for booster shots, others have said they could be beneficial for the elderly and other vulnerable populations, although it is unclear when they would be needed.     Some public health experts have also expressed concern that authorizing boosters in wealthy developed nations while other countries are still struggling against initial inoculations will further exacerbate vaccine inequity. (Reporting by Susan Heavey and Chris Prentice; additional reporting by Linda So; Editing by Chizu Nomiyama)((sheavey@thomsonreuters.com; +1-202-898-8300;))","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":252,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":148752921,"gmtCreate":1626022749663,"gmtModify":1631891492561,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3570188731963577","idStr":"3570188731963577"},"themes":[],"htmlText":"I’m buying&nbsp;","listText":"I’m buying&nbsp;","text":"I’m buying","images":[{"img":"https://static.tigerbbs.com/2a3918a00d848814cb589d5e7d2c62ad","width":"1125","height":"3068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/148752921","isVote":1,"tweetType":1,"viewCount":321,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":148976319,"gmtCreate":1625923866031,"gmtModify":1631891492570,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3570188731963577","idStr":"3570188731963577"},"themes":[],"htmlText":"Potential stocks","listText":"Potential stocks","text":"Potential stocks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/148976319","repostId":"1131738801","repostType":2,"repost":{"id":"1131738801","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1625645247,"share":"https://www.laohu8.com/m/news/1131738801?lang=&edition=full","pubTime":"2021-07-07 16:07","market":"us","language":"en","title":"XPeng shares fell 3% in premarket trading.","url":"https://stock-news.laohu8.com/highlight/detail?id=1131738801","media":"Tiger Newspress","summary":"XPeng shares fell 3% in premarket trading.\nShares of Chinese electric vehicle maker Xpeng Inc trade ","content":"<p>XPeng&nbsp;shares&nbsp;fell 3% in premarket&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/bfcb0a6ca8a7d5337dcf5cc5e4831321\" tg-width=\"1284\" tg-height=\"619\">Shares of Chinese electric vehicle&nbsp;maker Xpeng Inc&nbsp;trade as low as HK$159.30, down 3.5% from the offer price of HK$165 apiece in the company's dual primary listing debut in Hong Kong.</p>\n<p>Xpeng, which on Wednesday raised $1.8 bln by selling 85 mln shares in Hong Kong listing, will develop future models based on product platforms designed for international markets, its chief executive said</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>XPeng shares fell 3% in premarket trading.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nXPeng shares fell 3% in premarket trading.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-07-07 16:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>XPeng&nbsp;shares&nbsp;fell 3% in premarket&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/bfcb0a6ca8a7d5337dcf5cc5e4831321\" tg-width=\"1284\" tg-height=\"619\">Shares of Chinese electric vehicle&nbsp;maker Xpeng Inc&nbsp;trade as low as HK$159.30, down 3.5% from the offer price of HK$165 apiece in the company's dual primary listing debut in Hong Kong.</p>\n<p>Xpeng, which on Wednesday raised $1.8 bln by selling 85 mln shares in Hong Kong listing, will develop future models based on product platforms designed for international markets, its chief executive said</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"XPEV":"小鹏汽车"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1131738801","content_text":"XPeng shares fell 3% in premarket trading.\nShares of Chinese electric vehicle maker Xpeng Inc trade as low as HK$159.30, down 3.5% from the offer price of HK$165 apiece in the company's dual primary listing debut in Hong Kong.\nXpeng, which on Wednesday raised $1.8 bln by selling 85 mln shares in Hong Kong listing, will develop future models based on product platforms designed for international markets, its chief executive said","news_type":1,"symbols_score_info":{"XPEV":0.9}},"isVote":1,"tweetType":1,"viewCount":278,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":148978296,"gmtCreate":1625923806115,"gmtModify":1631891492572,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3570188731963577","idStr":"3570188731963577"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/148978296","repostId":"2149399869","repostType":2,"isVote":1,"tweetType":1,"viewCount":291,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":148971382,"gmtCreate":1625923653046,"gmtModify":1631891492576,"author":{"id":"3570188731963577","authorId":"3570188731963577","name":"SimonTeoh","avatar":"https://static.tigerbbs.com/357c30b86d9ab6c2455afb77b479e9eb","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3570188731963577","idStr":"3570188731963577"},"themes":[],"htmlText":"Awaiting&nbsp;","listText":"Awaiting&nbsp;","text":"Awaiting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/148971382","repostId":"1181198369","repostType":2,"isVote":1,"tweetType":1,"viewCount":486,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}